← FDA DRUG APPROVALS

FDA ANDA · ANDA062752

TETRACYCLINE HYDROCHLORIDE

Sponsor: CHARTWELL TETRA

APPLICATION
ANDA062752
TYPE
ANDA
ORIGINAL APPROVAL
1988-08-12
LATEST ACTION
2016-11-17
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

TETRACYCLINE HYDROCHLORIDEPrescription
TETRACYCLINE HYDROCHLORIDE 250MG · CAPSULE · ORAL
TETRACYCLINE HYDROCHLORIDEPrescription
TETRACYCLINE HYDROCHLORIDE 500MG · CAPSULE · ORAL

Approval history

2016-11-17Manufacturing (CMC) · Supplement 2 · unknownAP
1989-01-27Manufacturing (CMC) · Supplement 1AP
1988-08-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →